Matthew K Szot sold $174k of CVKD
Chief Financial Officer at Cadrenal Therapeutics, Inc.. 12,400 shares at an average of $14.05, traded Sep 24, 2025, filed Sep 26, 2025.
Score components
- +22RoleCFO
- +11Trade size$174k at market
- +10Share of holdings soldSold 40% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-25-092558, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 24, 2025 | SOpen-market sale Common Stock10b5-1 | -1,500 | $14.00 | $21k | 29,833 | Sep 26, 2025 |
| Sep 25, 2025 | SOpen-market sale Common Stock10b5-1 | -10,900 | $14.05 | $153k | 18,933 | Sep 26, 2025 |
Related signals
Other insiders at Cadrenal Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 11Weak | Cadrenal Therapeutics, Inc. | Quang X Pham Chairman, CEO and Interim CFO | $34k 11,156 shares | -10% | |
| 11Weak | Cadrenal Therapeutics, Inc. | Quang X Pham Chairman, CEO and Interim CFO | $40k 11,444 shares | -9% | |
| 5Weak | Cadrenal Therapeutics, Inc. | Quang X Pham Chairman, CEO and Interim CFO | $13k 4,126 shares | -3% | |
| 18Weak | Cadrenal Therapeutics, Inc. | Quang X Pham Chairman, CEO and Interim CFO | $70k 18,124 shares | -12% | |
| 20Weak | Cadrenal Therapeutics, Inc. | Quang X Pham Chairman, CEO and Interim CFO | $93k 22,385 shares | -13% | |
| 11Weak | Cadrenal Therapeutics, Inc. | Quang X Pham CEO and Chairman | $36k 8,285 shares | -5% | |
| 5Weak | Cadrenal Therapeutics, Inc. | Quang X Pham CEO and Chairman | $3,075 652 shares | -0% | |
| 13Weak | Cadrenal Therapeutics, Inc. | Quang X Pham CEO and Chairman | $69k 12,763 shares | -7% | |
| 5Weak | Cadrenal Therapeutics, Inc. | Quang X Pham CEO and Chairman | $6,629 1,165 shares | -1% | |
| 30Weak | Cadrenal Therapeutics, Inc. | Matthew K Szot Chief Financial Officer | $69k 9,933 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.